Francisco Longo

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 652 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +4

Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome

Lorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè et al. · Medicine · 2015 · 181 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Managing Competing Institutional Logics in Public–Private Joint Ventures

Ángel Saz‐Carranza, Francisco Longo · Public Management Review · 2012 · 123 citations

Management, Organization Studies, Public Administration +8

Frequency and significance of anti-Ro (SS-A) antibodies in multiple sclerosis patients

Clara de Andrés, A Guillem, Margarita Rodríguez‐Mahou et al. · Acta Neurologica Scandinavica · 2001 · 48 citations

Life Sciences, Immunology, Neurology +14

Pancreatitis induced by codeine: a case report with positive rechallenge

P Hastier, Francisco Longo, Martin Buckley et al. · Gut · 1997 · 26 citations · Full text

Medicine, Internal Medicine, Pharmacology +9